Capital Research Global Investors’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-82,644,367
| Closed | -$731M | – | 435 |
|
|
2023
Q1 | $731M | Sell |
82,644,367
-32,149,622
| -28% | -$285M | 0.21% | 104 |
|
|
2022
Q4 | $1.05B | Sell |
114,793,989
-2,396,339
| -2% | -$21.9M | 0.32% | 82 |
|
|
2022
Q3 | $946M | Buy |
117,190,328
+24,024,045
| +26% | +$194M | 0.31% | 83 |
|
|
2022
Q2 | $701M | Sell |
93,166,283
-38,999,232
| -30% | -$293M | 0.22% | 100 |
|
|
2022
Q1 | $1.24B | Sell |
132,165,515
-185,235
| -0.1% | -$1.74M | 0.31% | 78 |
|
|
2021
Q4 | $1.06B | Buy |
132,350,750
+13,474,099
| +11% | +$108M | 0.23% | 99 |
|
|
2021
Q3 | $1.16B | Sell |
118,876,651
-3,775,923
| -3% | -$36.8M | 0.27% | 87 |
|
|
2021
Q2 | $1.21B | Sell |
122,652,574
-6,040,649
| -5% | -$59.8M | 0.28% | 88 |
|
|
2021
Q1 | $1.49B | Sell |
128,693,223
-1,447,024
| -1% | -$16.7M | 0.36% | 67 |
|
|
2020
Q4 | $1.26B | Buy |
130,140,247
+32,778
| +0% | +$316K | 0.33% | 78 |
|
|
2020
Q3 | $1.17B | Sell |
130,107,469
-20,476
| -0% | -$184K | 0.35% | 66 |
|
|
2020
Q2 | $1.6B | Buy |
130,127,945
+37,144
| +0% | +$458K | 0.51% | 39 |
|
|
2020
Q1 | $1.17B | Sell |
130,090,801
-859,876
| -0.7% | -$7.72M | 0.46% | 54 |
|
|
2019
Q4 | $1.28B | Buy |
130,950,677
+21,250
| +0% | +$208K | 0.38% | 63 |
|
|
2019
Q3 | $901M | Buy |
130,929,427
+37,198
| +0% | +$256K | 0.3% | 81 |
|
|
2019
Q2 | $1.21B | Buy |
130,892,229
+2,700,837
| +2% | +$24.9M | 0.38% | 61 |
|
|
2019
Q1 | $2.01B | Buy |
128,191,392
+6,237,109
| +5% | +$97.8M | 0.64% | 42 |
|
|
2018
Q4 | $1.88B | Buy |
121,954,283
+3,105,683
| +3% | +$47.9M | 0.66% | 43 |
|
|
2018
Q3 | $2.56B | Sell |
118,848,600
-3,184,236
| -3% | -$68.6M | 0.74% | 34 |
|
|
2018
Q2 | $2.97B | Buy |
122,032,836
+363,631
| +0.3% | +$8.84M | 0.81% | 35 |
|
|
2018
Q1 | $2.08B | Buy |
121,669,205
+22,916,493
| +23% | +$392M | 0.59% | 48 |
|
|
2017
Q4 | $1.87B | Buy |
98,752,712
+28,656,135
| +41% | +$543M | 0.55% | 54 |
|
|
2017
Q3 | $1.23B | Sell |
70,096,577
-6,228,482
| -8% | -$110M | 0.37% | 69 |
|
|
2017
Q2 | $2.54B | Buy |
76,325,059
+9,260,426
| +14% | +$308M | 0.79% | 32 |
|
|
2017
Q1 | $2.15B | Buy |
67,064,633
+22,667,886
| +51% | +$727M | 0.68% | 42 |
|
|
2016
Q4 | $1.61B | Buy |
44,396,747
+23,520,998
| +113% | +$853M | 0.52% | 56 |
|
|
2016
Q3 | $960M | Buy |
20,875,749
+3,609,949
| +21% | +$166M | 0.32% | 79 |
|
|
2016
Q2 | $867M | Buy |
17,265,800
+5,722,500
| +50% | +$287M | 0.3% | 92 |
|
|
2016
Q1 | $618M | Buy |
11,543,300
+155,800
| +1% | +$8.34M | 0.21% | 122 |
|
|
2015
Q4 | $747M | Buy |
11,387,500
+7,675,500
| +207% | +$504M | 0.26% | 99 |
|
|
2015
Q3 | $210M | Hold |
3,712,000
| – | – | 0.07% | 219 |
|
|
2015
Q2 | $219M | Sell |
3,712,000
-5,518,700
| -60% | -$326M | 0.07% | 235 |
|
|
2015
Q1 | $575M | Sell |
9,230,700
-15,551,300
| -63% | -$969M | 0.2% | 126 |
|
|
2014
Q4 | $1.43B | Sell |
24,782,000
-6,410,152
| -21% | -$369M | 0.48% | 52 |
|
|
2014
Q3 | $1.68B | Sell |
31,192,152
-1,703,000
| -5% | -$91.5M | 0.58% | 45 |
|
|
2014
Q2 | $1.72B | Sell |
32,895,152
-10,492,148
| -24% | -$550M | 0.6% | 42 |
|
|
2014
Q1 | $2.29B | Sell |
43,387,300
-5,045,000
| -10% | -$267M | 0.83% | 27 |
|
|
2013
Q4 | $1.94B | Sell |
48,432,300
-10,634,616
| -18% | -$426M | 0.72% | 34 |
|
|
2013
Q3 | $2.23B | Buy |
59,066,916
+884,016
| +2% | +$33.4M | 0.88% | 25 |
|
|
2013
Q2 | $2.28B | Buy |
+58,182,900
| New | +$2.28B | 0.97% | 22 |
|